2605832|t|[The significance of measurement of contents of serum serine protease inhibitors in senile dementia of the Alzheimer type].
2605832|a|We have evaluated serum alpha 1-antichymotrypsin content in dementia of the Alzheimer type (DAT). The subjects consisted of 26 patients with DAT, 15 with cerebrovascular dementia, 10 with mixed type dementia, 2 with Down syndrome, 17 with Parkinson disease, 14 with spinocerebellar degeneration, 14 with cerebrovascular disease without dementia, 12 with Duchenne muscular dystrophy and 77 normal controls. DAT group showed statistically significant increase of serum alpha 1-antichymotrypsin content, as compared with normal control group (p less than 0.001), mixed type dementia group (p less than 0.05) and other 6 groups (p less than 0.001). However, the levels of both alpha 1-antitrypsin content and inter-alpha-trypsin inhibitor content, included in serine protease inhibitors, were not significantly different between DAT and normal control groups. These findings indicated that measurement of serum alpha 1-antichymotrypsin is useful as the diagnostic marker of DAT.
2605832	84	99	senile dementia	Disease	MESH:D000544
2605832	107	116	Alzheimer	Disease	MESH:D000544
2605832	148	172	alpha 1-antichymotrypsin	Gene	12
2605832	184	192	dementia	Disease	MESH:D003704
2605832	200	209	Alzheimer	Disease	MESH:D000544
2605832	251	259	patients	Species	9606
2605832	278	302	cerebrovascular dementia	Disease	MESH:D003704
2605832	323	331	dementia	Disease	MESH:D003704
2605832	340	353	Down syndrome	Disease	MESH:D004314
2605832	363	380	Parkinson disease	Disease	MESH:D010300
2605832	390	418	spinocerebellar degeneration	Disease	MESH:D013132
2605832	428	451	cerebrovascular disease	Disease	MESH:D002561
2605832	460	468	dementia	Disease	MESH:D003704
2605832	478	505	Duchenne muscular dystrophy	Disease	MESH:D020388
2605832	591	615	alpha 1-antichymotrypsin	Gene	12
2605832	695	703	dementia	Disease	MESH:D003704
2605832	797	816	alpha 1-antitrypsin	Gene	5265
2605832	1031	1055	alpha 1-antichymotrypsin	Gene	12

